COM:GRIBIO
GRI Bio, Inc.
- Stock
Last Close
1.27
26/07 20:00
Market Cap
1.59M
Beta: -
Volume Today
457.28K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 736.16K - | 675.50K - | 1.35M 100.15% | |||
average receivables | ||||||
book value per share | 99.09 - | -44.83 145.24% | -1.60 96.44% | -0.55 65.60% | 0.56 202.11% | |
capex per share | -0.06 - | -0.00 - | -0.02 1,608.44% | |||
capex to depreciation | -0.03 - | -0.06 - | -0.14 133.92% | |||
capex to operating cash flow | 0.00 - | 0.00 - | 0.00 68.34% | |||
capex to revenue | -0.02 - | |||||
cash per share | 117.81 - | 3.36 97.15% | 0.03 99.09% | 0.00 90% | 3.92 128,602.53% | |
days of inventory on hand | ||||||
days payables outstanding | 122.33K - | 9.03K - | ||||
days sales outstanding | ||||||
debt to assets | 0.02 - | 0.17 767.57% | 16.58 9,437.33% | 1.76 89.40% | 0.00 99.73% | |
debt to equity | 0.03 - | -0.11 528.31% | -0.77 570.09% | -0.41 45.86% | 0.05 113.05% | |
dividend yield | ||||||
earnings yield | -2.21 - | -0.09 95.73% | -0.00 96.98% | -0.14 4,740.19% | -10.50 7,526.53% | |
enterprise value | -1.91M - | 51.45M 2,792.81% | 534.03M 938.05% | 26.39M 95.06% | -552.39K 102.09% | |
enterprise value over ebitda | 0.61 - | -10.92 1,901.88% | -527.17 4,729.54% | -12.06 97.71% | 0.05 100.40% | |
ev to operating cash flow | 0.66 - | -13.88 2,195.34% | -630.49 4,441.93% | -24.32 96.14% | 0.06 100.25% | |
ev to sales | 514.45 - | |||||
free cash flow per share | -88.91 - | -114.33 28.58% | -0.29 99.75% | -0.37 28.45% | -19.82 5,286.77% | |
free cash flow yield | -1.84 - | -0.07 96.06% | -0.00 97.79% | -0.04 2,548.80% | -7.37 17,321.90% | |
graham net net | 85.07 - | -70.92 183.36% | -1.64 97.69% | -0.68 58.80% | -1.93 184.92% | |
graham number | 488.02 - | 387.26 20.65% | 4.28 98.89% | 3.85 10.14% | 18.88 390.70% | |
income quality | 0.83 - | 0.77 7.67% | 0.54 29.31% | 0.34 37.92% | 0.70 107.87% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -16.01 - | -140.82 779.59% | -1.94 98.62% | -3.43 76.61% | -5.47 59.51% | |
interest debt per share | 8.72 - | 6.17 29.25% | 1.41 77.18% | 0.45 68.13% | 4.54 912.70% | |
inventory turnover | ||||||
invested capital | 0.03 - | -0.11 528.31% | -0.77 570.09% | -0.41 45.86% | 0.05 113.05% | |
market cap | 1.57M - | 51.22M 3,161.46% | 530.50M 935.77% | 25.73M 95.15% | 1.24M 95.17% | |
net current asset value | 2.86M - | -1.74M 160.67% | -4.85M 179.31% | -1.70M 64.92% | 237K 113.94% | |
net debt to ebitda | 1.10 - | -0.05 104.36% | -3.48 7,122.67% | -0.30 91.28% | 0.16 152.20% | |
net income per share | -106.82 - | -148.68 39.18% | -0.51 99.66% | -1.20 134.72% | -28.25 2,258.09% | |
operating cash flow per share | -88.91 - | -114.27 28.51% | -0.29 99.75% | -0.37 28.10% | -19.80 5,296.94% | |
payables turnover | 0.00 - | 0.04 - | ||||
receivables turnover | ||||||
research and ddevelopement to revenue | 37.07 - | |||||
return on tangible assets | -0.81 - | -5.05 523.14% | -6.92 37.09% | -9.25 33.60% | -4.41 52.31% | |
revenue per share | 3.08 - | |||||
roe | -1.08 - | 3.32 407.64% | 0.32 90.37% | 2.18 582.36% | -50.34 2,409.31% | |
roic | -0.89 - | 4.28 582.49% | 1.03 75.90% | 2.80 171.12% | -41.71 1,590.63% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 99.09 - | -44.83 145.24% | -1.60 96.44% | -0.55 65.60% | 0.56 202.11% | |
stock based compensation to revenue | ||||||
tangible asset value | 3.21M - | -1.45M 145.24% | -4.72M 224.90% | -1.63M 65.60% | 259K 115.94% | |
tangible book value per share | 99.09 - | -44.83 145.24% | -1.60 96.44% | -0.55 65.60% | 0.56 202.11% | |
working capital | 3.11M - | -1.55M 149.80% | -4.78M 208.12% | -1.69M 64.72% | 237K 114.06% |
All numbers in (except ratios and percentages)